Showing results (1751-1760 of 2,473) with videos related to

Sort By:
Pageof 248
Cancer Treatment Reviews|February 12, 2023
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysisMarco Filetti, Pasquale Lombardi, Raffaele Giusti, et al.
Cancer Treatment Reviews|March 10, 2023
Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysisYakup Ergun, Gokhan Ucar, Baran Akagunduz
Cancer Treatment Reviews|March 7, 2025
Assessment and stratification of cardiovascular disease risk in people diagnosed with breast cancer: A scoping reviewMi Hye Jeon, Tracey DiSipio, Louise Wilson, et al.
Cancer Treatment Reviews|March 6, 2025
Current controversies in the use of Oncotype DX in early breast cancerPier Paolo M Berton Giachetti, Ambra Carnevale Schianca, Dario Trapani, et al.
Cancer Treatment Reviews|February 28, 2025
Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axisTarek Assi, Tania Moussa, Carine Ngo, et al.
Cancer Treatment Reviews|February 19, 2025
Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapyGabrielle Knafler, Alan L Ho, Kathleen N Moore, et al.
Cancer Treatment Reviews|January 24, 2025
Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussionStavroula L Kastora, Eirini Pantiora, Yong Hwa Hong, et al.
Cancer Treatment Reviews|November 1, 2024
Local administration of immunotherapy for patients with skin cancer: A systematic reviewJ C Janssen, B van Dijk, L L Hoeijmakers, et al.
Cancer Treatment Reviews|November 21, 2024
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and ImmunotherapyChiara Corti, Busem Binboğa Kurt, Beyza Koca, et al.
Cancer Treatment Reviews|November 29, 2024
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancerVolkmar Müller, Thomas Bachelot, Giuseppe Curigliano, et al.
Pageof 248